House dust mite‐specific IgA2 is associated with protection against eczema in allergic patients. Issue 4 (18th January 2016)

• Record Type: Journal Article
• Authors: den Hartog, G.; van Neerven, R. J. J.; Boot, J. D.; Jansen, A. P. H.; Savelkoul, H. F. J.
• Is Part Of: Allergy. Volume 71:Issue 4(2016:Apr.)
• Page Start: 563
• Page End: 566
• Publication Date: 2016-01-18
• Subjects: eczema -- house dust mite allergy -- IgA -- saliva -- serum; Allergy -- Periodicals; 616.97
• DOI: 10.1111/all.12807
• Languages: English
• ISSNs: 0105-4538

Abstract

Abstract: Upon inhalation, house dust mite (HDM) allergens are deposited at the nasal and oral mucosa, where IgA is produced abundantly. IgA subclasses have been linked to protection against respiratory allergy previously. It is currently not known whether and how the human IgA subclasses IgA1 and IgA2 contribute to the clinical status of house dust mite‐allergic patients. Saliva and serum samples were collected, and HDM‐specific, IgE, IgG4, IgA1 and IgA2 levels were determined. HDM‐specific levels of IgA in serum were similar to levels measured in nonallergic controls, but HDM‐specific levels of IgA2 in saliva were decreased in allergic subjects. HDM‐allergic patients who suffered from rhinitis and eczema showed a significant decrease in IgA2‐levels compared to patients who suffered from rhinitis only. Taken together, our findings indicate that HDM‐specific IgA2, but not IgA1, levels in serum and saliva are reduced in HDM‐allergic patients suffering from eczema.